Recent News


October 26, 2020

Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™ Study in Cataplexy or Excessive Daytime Sleepiness in Patients with Narcolepsy

DUBLIN, Oct. 20, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the publication of the global Phase 3 double-blind, placebo-controlled, randomized-withdrawal, multicenter study of Xywav™ (calcium, magnesium, potassium and sodium oxybates) oral ...
September 29, 2020

Sleep Apnea Screening in Truck and Rail Industries

With the recent changes in the final rule implemented by the Federal Motor Carrier Safety Administration, the AAHS has published a position statement on sleep apnea screening in trucking and rail industries.
September 30, 2020

The AAHS Submits Comments in response to the NHTSA National Survey of Drowsy Driving Knowledge, Attitudes and Behaviors

As an organization dedicated to improving the lives of patients with sleep disorders and spreading awareness for the importance of healthy sleep practices, the AAHS supports and commends the NHTSA’s efforts to gather data on drowsy driving, which will inform drowsy driving ...